0 CHECKOUT

Epilepsy - Pipeline Review, H1 2015

  • ID: 3106245
  • January 2015
  • 330 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Acorda Therapeutics, Inc.
  • Astellas Pharma Inc.
  • Biovista Inc.
  • Eisai Co., Ltd.
  • INSYS Therapeutics, Inc.
  • Pfizer Inc.
  • MORE

Epilepsy - Pipeline Review, H1 2015

Summary

This, ‘Epilepsy - Pipeline Review, H1 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epilepsy and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acorda Therapeutics, Inc.
  • Astellas Pharma Inc.
  • Biovista Inc.
  • Eisai Co., Ltd.
  • INSYS Therapeutics, Inc.
  • Pfizer Inc.
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Epilepsy Overview
Therapeutics Development
Pipeline Products for Epilepsy - Overview
Pipeline Products for Epilepsy - Comparative Analysis
Epilepsy - Therapeutics under Development by Companies
Epilepsy - Therapeutics under Investigation by Universities/Institutes
Epilepsy - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Epilepsy - Products under Development by Companies
Epilepsy - Products under Investigation by Universities/Institutes
Epilepsy - Companies Involved in Therapeutics Development
Acorda Therapeutics, Inc.
Adamas Pharmaceuticals, Inc.
Advicenne Pharma
Aeolus Pharmaceuticals, Inc.
Aestus Therapeutics, Inc.
Alexza Pharmaceuticals, Inc.
Allergan, Inc.
Anavex Life Sciences Corp.
Asklepios BioPharmaceutical, Inc.
Astellas Pharma Inc.
Bial - Portela & Ca, S.A.
BioCrea GmbH
Bionomics Limited
Biovista Inc.
Catalyst Pharmaceutical Partners, Inc.
Celentyx Ltd.
Chong Kun Dang Pharmaceutical Corp.
Concert Pharmaceuticals, Inc.
Convergence Pharmaceuticals Ltd.
D-Pharm Ltd.
Desitin Arzneimittel GmbH
Eisai Co., Ltd.
Epirus Biopharmaceuticals, Inc.
Glialogix, Inc.
GW Pharmaceuticals plc
H. Lundbeck A/S
INSYS Therapeutics, Inc.
Iproteos S.L.
Knopp Biosciences LLC
Ligand Pharmaceuticals, Inc.
Lipicard Technologies Limited
Lohocla Research Corporation
Marathon Pharmaceuticals, LLC
MarcoPolo Pharmaceuticals SA
Marinus Pharmaceuticals, Inc.
MedGenesis Therapeutix Inc.
Neurocrine Biosciences, Inc.
Novartis AG
Pfizer Inc.
PharmatrophiX, Inc.
RestorGenex Corporation
Retrophin Inc.
Sage Therapeutics
Saniona AB
SciFluor Life Sciences, LLC
SK Biopharmaceuticals Co., Ltd.
UCB S.A.
Ultragenyx Pharmaceutical Inc.
Upsher-Smith Laboratories, Inc.
Vichem Chemie Research Ltd.
VistaGen Therapeutics, Inc.
Zynerba Pharmaceuticals, Inc.
Epilepsy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
2-DG - Drug Profile
ADD-405008 - Drug Profile
ADS-8800 Series - Drug Profile
ADV-5803 - Drug Profile
ADV-6208 - Drug Profile
ADV-6769 - Drug Profile
ADV-6770 - Drug Profile
AEOL-1114B - Drug Profile
AEOL-11203 - Drug Profile
AEOL-11207 - Drug Profile
alprazolam - Drug Profile
ANAVEX-2-73 - Drug Profile
AV-101 - Drug Profile
AVL-5189 - Drug Profile
BNP-TLE - Drug Profile
brivaracetam - Drug Profile
BVA-601 - Drug Profile
C-10068 - Drug Profile
cannabidiol - Drug Profile
carbamazepine - Drug Profile
carisbamate - Drug Profile
CCG-63802 - Drug Profile
Cell Therapy for Parkinson's Disease and Epilepsy - Drug Profile
CHEC-9 - Drug Profile
CKD-903 - Drug Profile
CNV-1061436 - Drug Profile
cosyntropin - Drug Profile
CPP-115 - Drug Profile
CX-1010 - Drug Profile
diazepam - Drug Profile
diazepam - Drug Profile
diazepam - Drug Profile
DP-VPA - Drug Profile
Drug for Epilepsy - Drug Profile
Drug to Agonize GABA Receptor for Epilepsy - Drug Profile
Drugs to Inhibit MAPK for Epilepsy and Behavioral Disorders - Drug Profile
EMSP - Drug Profile
Epidiolex - Drug Profile
ESB - Drug Profile
ESBB - Drug Profile
eslicarbazepine acetate - Drug Profile
everolimus - Drug Profile
fosphenytoin sodium - Drug Profile
FV-082 - Drug Profile
FV-137 - Drug Profile
ganaxolone - Drug Profile
Gene Therapy to Activate Neuropeptide Y Receptor Y2 and Y5 for Epilepsy - Drug Profile
GLX-1112 - Drug Profile
GWP-42003-P - Drug Profile
GWP-42006 - Drug Profile
IPR-003 - Drug Profile
KM-113 - Drug Profile
KM-314 - Drug Profile
lacosamide - Drug Profile
lamotrigine - Drug Profile
levetiracetam - Drug Profile
levetiracetam - Drug Profile
liatermin - Drug Profile
LT-4121 - Drug Profile
LT-4122 - Drug Profile
LT-4123 - Drug Profile
LT-4124 - Drug Profile
LT-4125 - Drug Profile
LT-4126 - Drug Profile
MB-003 - Drug Profile
midazolam hydrochloride - Drug Profile
MRS-5474 - Drug Profile
MSP - Drug Profile
naluzotan - Drug Profile
NB-23R1 - Drug Profile
NGT-168 - Drug Profile
P-529 - Drug Profile
perampanel - Drug Profile
PF-04895162 - Drug Profile
PRTT-200 - Drug Profile
Remegal - Drug Profile
rufinamide - Drug Profile
SAGE-217 - Drug Profile
SAGE-547 - Drug Profile
SAGE-689 - Drug Profile
SCT-66 - Drug Profile
selurampanel - Drug Profile
SF-0034 - Drug Profile
SGE-102 - Drug Profile
Small Molecule 1 to Block Sodium Channels for Cancer Pain and Epilepsy - Drug Profile
Small Molecule 2 to Block Sodium Channels for Cancer Pain and Epilepsy - Drug Profile
Small Molecule 3 to Block Sodium Channels for Cancer Pain and Epilepsy - Drug Profile
Small Molecule for Central Nervous System - Drug Profile
Small Molecule to Activate Kv7.2 and Kv7.3 Channels for Epilepsy and Pain - Drug Profile
Small Molecule to Agonize GABAA Receptor Subunit Alpha-4 and Gamma for Epilepsy - Drug Profile
Small Molecule to Antagonize mGluR5 and mGluR6 for Neurological Disorders - Drug Profile
Small Molecule to Inhibit GABA Transaminase for Migraine and Status Epilepticus - Drug Profile
Small Molecules for CNS Disorders - Drug Profile
Small Molecules for Epilepsy - Drug Profile
Small Molecules to Activate GABAA Receptor and Antagonize NMDA Receptor for CNS - Drug Profile
Small Molecules to Activate Kv7 for Neuropathic Pain, Epilepsy and Tinnitus - Drug Profile
Small Molecules to Activate TrkB Receptor for Central Nervous System, Metabolic Disorders and ENT Disorders - Drug Profile
Small Molecules to Agonize GABA-A Receptor For Epilepsy - Drug Profile
Small Molecules to Agonize GABAA-Beta 2 Receptor for Epilepsy and Autism - Drug Profile
Small Molecules to Agonize TrkB for Ophthalmology and Central Nervous System - Drug Profile
Small Molecules to Antagonize TLR-4 for CNS Disorders - Drug Profile
Small Molecules to Inhibit Dynamin for Epilepsy and Oncology - Drug Profile
sulthiame - Drug Profile
TG-4155 - Drug Profile
tonabersat - Drug Profile
topiramate - Drug Profile
UBP-608 - Drug Profile
UX-007 - Drug Profile
VAD-1 - Drug Profile
VAD-2 - Drug Profile
VB-3323 - Drug Profile
VID-45110 - Drug Profile
VLB-01 - Drug Profile
VU-0456810 - Drug Profile
YKP-3089 - Drug Profile
Z-944 - Drug Profile
ZYN-002 - Drug Profile
Epilepsy - Recent Pipeline Updates
Epilepsy - Dormant Projects
Epilepsy - Discontinued Products
Epilepsy - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Epilepsy, H1 2015
Number of Products under Development for Epilepsy - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Epilepsy - Pipeline by Acorda Therapeutics, Inc., H1 2015
Epilepsy - Pipeline by Adamas Pharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by Advicenne Pharma, H1 2015
Epilepsy - Pipeline by Aeolus Pharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by Aestus Therapeutics, Inc., H1 2015
Epilepsy - Pipeline by Alexza Pharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by Allergan, Inc., H1 2015
Epilepsy - Pipeline by Anavex Life Sciences Corp., H1 2015
Epilepsy - Pipeline by Asklepios BioPharmaceutical, Inc., H1 2015
Epilepsy - Pipeline by Astellas Pharma Inc., H1 2015
Epilepsy - Pipeline by Bial - Portela & Ca, S.A., H1 2015
Epilepsy - Pipeline by BioCrea GmbH, H1 2015
Epilepsy - Pipeline by Bionomics Limited, H1 2015
Epilepsy - Pipeline by Biovista Inc., H1 2015
Epilepsy - Pipeline by Catalyst Pharmaceutical Partners, Inc., H1 2015
Epilepsy - Pipeline by Celentyx Ltd., H1 2015
Epilepsy - Pipeline by Chong Kun Dang Pharmaceutical Corp., H1 2015
Epilepsy - Pipeline by Concert Pharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by Convergence Pharmaceuticals Ltd., H1 2015
Epilepsy - Pipeline by D-Pharm Ltd., H1 2015
Epilepsy - Pipeline by Desitin Arzneimittel GmbH, H1 2015
Epilepsy - Pipeline by Eisai Co., Ltd., H1 2015
Epilepsy - Pipeline by Epirus Biopharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by Glialogix, Inc., H1 2015
Epilepsy - Pipeline by GW Pharmaceuticals plc, H1 2015
Epilepsy - Pipeline by H. Lundbeck A/S, H1 2015
Epilepsy - Pipeline by INSYS Therapeutics, Inc., H1 2015
Epilepsy - Pipeline by Iproteos S.L., H1 2015
Epilepsy - Pipeline by Knopp Biosciences LLC, H1 2015
Epilepsy - Pipeline by Ligand Pharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by Lipicard Technologies Limited, H1 2015
Epilepsy - Pipeline by Lohocla Research Corporation, H1 2015
Epilepsy - Pipeline by Marathon Pharmaceuticals, LLC, H1 2015
Epilepsy - Pipeline by MarcoPolo Pharmaceuticals SA, H1 2015
Epilepsy - Pipeline by Marinus Pharmaceuticals, Inc., H1 2015
Epilepsy - Pipeline by MedGenesis Therapeutix Inc., H1 2015
Epilepsy - Pipeline by Neurocrine Biosciences, Inc., H1 2015
Epilepsy - Pipeline by Novartis AG, H1 2015
Epilepsy - Pipeline by Pfizer Inc., H1 2015
Epilepsy - Pipeline by PharmatrophiX, Inc., H1 2015
Epilepsy - Pipeline by RestorGenex Corporation, H1 2015
Epilepsy - Pipeline by Retrophin Inc., H1 2015
Epilepsy - Pipeline by Sage Therapeutics, H1 2015
Epilepsy - Pipeline by Saniona AB, H1 2015
Epilepsy - Pipeline by SciFluor Life Sciences, LLC, H1 2015
Epilepsy - Pipeline by SK Biopharmaceuticals Co., Ltd., H1 2015
Epilepsy - Pipeline by UCB S.A., H1 2015
Epilepsy - Pipeline by Ultragenyx Pharmaceutical Inc., H1 2015
Epilepsy - Pipeline by Upsher-Smith Laboratories, Inc., H1 2015
Epilepsy - Pipeline by Vichem Chemie Research Ltd., H1 2015
Epilepsy - Pipeline by VistaGen Therapeutics , Inc., H1 2015
Epilepsy - Pipeline by Zynerba Pharmaceuticals, Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Epilepsy Therapeutics - Recent Pipeline Updates, H1 2015
Epilepsy - Dormant Projects, H1 2015
Epilepsy - Dormant Projects (Contd..1), H1 2015
Epilepsy - Dormant Projects (Contd..2), H1 2015
Epilepsy - Dormant Projects (Contd..3), H1 2015
Epilepsy - Dormant Projects (Contd..4), H1 2015
Epilepsy - Dormant Projects (Contd..5), H1 2015
Epilepsy - Discontinued Products, H1 2015
Epilepsy - Discontinued Products (Contd..1), H1 2015

List of Figures
Number of Products under Development for Epilepsy, H1 2015
Number of Products under Development for Epilepsy - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Acorda Therapeutics, Inc.
Adamas Pharmaceuticals, Inc.
Advicenne Pharma
Aeolus Pharmaceuticals, Inc.
Aestus Therapeutics, Inc.
Alexza Pharmaceuticals, Inc.
Allergan, Inc.
Anavex Life Sciences Corp.
Asklepios BioPharmaceutical, Inc.
Astellas Pharma Inc.
Bial - Portela & Ca, S.A.
BioCrea GmbH
Bionomics Limited
Biovista Inc.
Catalyst Pharmaceutical Partners, Inc.
Celentyx Ltd.
Chong Kun Dang Pharmaceutical Corp.
Concert Pharmaceuticals, Inc.
Convergence Pharmaceuticals Ltd.
D-Pharm Ltd.
Desitin Arzneimittel GmbH
Eisai Co., Ltd.
Epirus Biopharmaceuticals, Inc.
Glialogix, Inc.
GW Pharmaceuticals plc
H. Lundbeck A/S
INSYS Therapeutics, Inc.
Iproteos S.L.
Knopp Biosciences LLC
Ligand Pharmaceuticals, Inc.
Lipicard Technologies Limited
Lohocla Research Corporation
Marathon Pharmaceuticals, LLC
MarcoPolo Pharmaceuticals SA
Marinus Pharmaceuticals, Inc.
MedGenesis Therapeutix Inc.
Neurocrine Biosciences, Inc.
Novartis AG
Pfizer Inc.
PharmatrophiX, Inc.
RestorGenex Corporation
Retrophin Inc.
Sage Therapeutics
Saniona AB
SciFluor Life Sciences, LLC
SK Biopharmaceuticals Co., Ltd.
UCB S.A.
Ultragenyx Pharmaceutical Inc.
Upsher-Smith Laboratories, Inc.
Vichem Chemie Research Ltd.
VistaGen Therapeutics, Inc.
Zynerba Pharmaceuticals, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Shire PLC.
  • GlaxoSmithKline PLC
  • Astrazeneca PLC
  • Roche Diagnostics Ltd.
  • H. Lundbeck A/S
  • Electrical Geodesics, Inc.